Arteris (NASDAQ:AIP – Get Free Report) is anticipated to release its Q3 2026 results after the market closes on Thursday, November 5th. Analysts expect Arteris to announce earnings of ($0.04) per share and revenue of $24.50 million for the quarter. Parties can check the company’s upcoming Q3 2026 earnings report for the latest details on the call scheduled for Thursday, November 5, 2026 at 4:30 PM ET.
Arteris (NASDAQ:AIP – Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by ($0.06). Arteris had a negative return on equity of 295.96% and a negative net margin of 46.70%. The firm had revenue of $24.13 million during the quarter, compared to the consensus estimate of $23.48 million. On average, analysts expect Arteris to post ($0.68) EPS for the current fiscal year and ($0.37) EPS for the next fiscal year.
Arteris Stock Down 5.1%
AIP opened at $17.85 on Tuesday. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.57 and a quick ratio of 1.57. The company’s 50-day moving average is $21.83 and its 200 day moving average is $24.94. Arteris has a fifty-two week low of $12.06 and a fifty-two week high of $50.26.
Analyst Ratings Changes
AIP has been the subject of several analyst reports. Rosenblatt Securities reiterated a “buy” rating and issued a $38.00 price objective on shares of Arteris in a research note on Friday, August 7th. Oppenheimer initiated coverage on shares of Arteris in a research report on Thursday, July 16th. They set an “outperform” rating and a $40.00 target price on the stock. TD Cowen cut their target price on Arteris from $40.00 to $25.00 and set a “buy” rating on the stock in a research note on Monday, October 19th. Craig Hallum assumed coverage on Arteris in a report on Monday, September 21st. They issued a “buy” rating and a $30.00 target price for the company. Finally, Jefferies Financial Group raised Arteris from a “hold” rating to a “buy” rating and upped their target price for the company from $35.00 to $50.00 in a report on Friday, August 7th. Six research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Arteris presently has an average rating of “Moderate Buy” and an average target price of $37.29.
View Our Latest Stock Analysis on AIP
Insider Buying and Selling
In related news, COO Laurent R. Moll sold 12,219 shares of the firm’s stock in a transaction dated Monday, October 5th. The shares were sold at an average price of $24.29, for a total transaction of $296,799.51. Following the completion of the sale, the chief operating officer owned 194,659 shares in the company, valued at approximately $4,728,267.11. This trade represents a 5.91% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Nicholas B. Hawkins sold 10,431 shares of Arteris stock in a transaction dated Thursday, August 13th. The stock was sold at an average price of $28.26, for a total transaction of $294,780.06. Following the completion of the sale, the chief financial officer directly owned 95,666 shares in the company, valued at approximately $2,703,521.16. This represents a 9.83% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 478,631 shares of company stock worth $10,823,565 in the last ninety days. Corporate insiders own 23.30% of the company’s stock.
Arteris Company Profile
Arteris, Inc is a semiconductor intellectual property (IP) company that provides technology used to design and integrate complex systems-on-chip (SoCs). Its products help semiconductor and system developers connect, manage and verify the various processing, memory and specialized functional components incorporated into modern chips.
The company’s portfolio includes network-on-chip (NoC) interconnect and semiconductor IP solutions, including its FlexNoC interconnect technology, Ncore cache-coherent interconnect IP and CodaCache products.
Read More
- Five stocks we like better than Arteris
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AIāThese 5 Stocks Are Getting Paid
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.
